Jamile M Shammo Selected Research

Jamile M Shammo Research Topics

Disease

4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 01/2008
3	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 09/2011
3	Anemia 01/2022 - 01/2008
3	Polycythemia Vera 01/2022 - 09/2011
2	Essential Thrombocythemia 01/2022 - 09/2011
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 12/2020 - 12/2020
2	Iron Overload 01/2018 - 01/2016
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2017 - 11/2011
2	Cytopenia 07/2012 - 06/2005
2	Neoplasms (Cancer) 11/2011 - 09/2011
1	von Willebrand Diseases (von Willebrand's Disease) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Thrombocytosis (Thrombocythemia) 01/2022
1	Hemolytic Anemia 12/2020
1	Fatigue 12/2020
1	Hemolysis 12/2020
1	Infections 12/2020
1	Bone Marrow Failure Disorders 07/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Thalassemia 01/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2015
1	Lymphoma (Lymphomas) 12/2011
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2011
1	Thrombocytopenia (Thrombopenia) 11/2010
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2010
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2008
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2005
1	Febrile Neutropenia 06/2005
1	Neutropenia 06/2005
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2005

Drug/Important Bio-Agent (IBA)

2	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2022 - 10/2021
2	Complement System Proteins (Complement)IBA 12/2020 - 12/2020
2	IronIBA 01/2018 - 01/2016
2	Deferasirox FDA Link 01/2018 - 01/2016
2	Lenalidomide (CC 5013)FDA Link 01/2017 - 01/2008
2	fludarabineIBA 12/2011 - 06/2005
2	Rituximab (Mabthera)FDA Link 12/2011 - 11/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2011 - 06/2005
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2011 - 06/2005
1	Janus Kinase InhibitorsIBA 01/2022
1	anagrelide (Agrylin)FDA LinkGeneric 01/2022
1	fedratinibIBA 01/2022
1	luspaterceptIBA 01/2022
1	LigandsIBA 01/2022
1	ruxolitinibIBA 10/2021
1	eculizumab FDA Link 12/2020
1	Blood Proteins (Serum Proteins)IBA 12/2020
1	Oxidoreductases (Dehydrogenase)IBA 12/2020
1	Monoclonal AntibodiesIBA 12/2020
1	ravulizumabIBA 12/2020
1	BilirubinIBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	TESIBA 07/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019
1	olaparibIBA 01/2019
1	ChromatinIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	TabletsIBA 01/2016
1	Iron Chelating AgentsIBA 01/2016
1	DeferiproneIBA 01/2016
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2016
1	Chelating AgentsIBA 01/2016
1	Insulin-Like PeptidesIBA 01/2015
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2015
1	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2011
1	ibritumomab tiuxetan (Zevalin)FDA Link 12/2011
1	Yttrium-90IBA 12/2011
1	Prednisone (Sone)FDA LinkGeneric 11/2011
1	Vincristine (Oncovin)FDA LinkGeneric 11/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2011
1	Aligeron (AS 2)IBA 09/2011
1	eltrombopag FDA Link 11/2010
1	Alkylating AgentsIBA 06/2005

Therapy/Procedure

6	Therapeutics 01/2022 - 06/2005
2	Radioimmunotherapy 04/2017 - 12/2011
2	Drug Therapy (Chemotherapy) 07/2012 - 11/2011
1	Chelation Therapy (Therapy, Chelation) 01/2018
1	Blood Transfusion (Blood Transfusions) 01/2016
1	Drug Tapering 06/2005